Hypertension and burden of myocardial infarction in China: risk factors, gender differences and temporal trends from a National Chronic Disease Surveillance study (2021-2023).

IF 2.3 4区 医学
Blood Pressure Pub Date : 2025-12-01 Epub Date: 2025-04-10 DOI:10.1080/08037051.2025.2487584
Xiaoling Zhang, Dan Huang, Jianxun Zhao, Jinhui Wu
{"title":"Hypertension and burden of myocardial infarction in China: risk factors, gender differences and temporal trends from a National Chronic Disease Surveillance study (2021-2023).","authors":"Xiaoling Zhang, Dan Huang, Jianxun Zhao, Jinhui Wu","doi":"10.1080/08037051.2025.2487584","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Myocardial infarction (MI) remains a leading global cause of morbidity and mortality, with rising prevalence in China. Hypertension persists as a predominant modifiable risk factor. This study investigates MI prevalence, trends and risk factors using data from China CDC's Chronic Disease Surveillance program. <b>Methods:</b> Data from 258,742 participants (2021-2023) were analysed. Demographic characteristics, risk factors and gender/urban-rural disparities in MI prevalence were assessed. Multivariate logistic regression identified significant risk factors. <b>Results:</b> Hypertension was the leading MI risk factor (64.3%), followed by dyslipidaemia (58.6%) and smoking (42.3%). Men had higher MI prevalence than women (58.2% <i>vs</i>. 41.8%), and urban residents surpassed rural residents (56.7% <i>vs.</i> 43.3%), with significant lifestyle disparities (e.g. physical inactivity and smoking). Multivariate analysis identified age ≥ 60 years (OR = 2.75, 95% CI: 2.46-3.08), hypertension, dyslipidaemia, smoking and obesity (BMI ≥ 25) as key risk factors. MI incidence increased by 3.14% nationally from 2021 to 2023. <b>Conclusions:</b> China's MI burden is escalating, with notable gender, age and residence disparities. Older adults and individuals with hypertension, dyslipidaemia, smoking or obesity face elevated risks. Hypertension contributes to nearly two-thirds of MI cases, emphasising the urgency for targeted prevention strategies, particularly in high-risk groups (hypertensive individuals, older adults and urban populations).</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"2487584"},"PeriodicalIF":2.3000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Pressure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08037051.2025.2487584","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/10 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Myocardial infarction (MI) remains a leading global cause of morbidity and mortality, with rising prevalence in China. Hypertension persists as a predominant modifiable risk factor. This study investigates MI prevalence, trends and risk factors using data from China CDC's Chronic Disease Surveillance program. Methods: Data from 258,742 participants (2021-2023) were analysed. Demographic characteristics, risk factors and gender/urban-rural disparities in MI prevalence were assessed. Multivariate logistic regression identified significant risk factors. Results: Hypertension was the leading MI risk factor (64.3%), followed by dyslipidaemia (58.6%) and smoking (42.3%). Men had higher MI prevalence than women (58.2% vs. 41.8%), and urban residents surpassed rural residents (56.7% vs. 43.3%), with significant lifestyle disparities (e.g. physical inactivity and smoking). Multivariate analysis identified age ≥ 60 years (OR = 2.75, 95% CI: 2.46-3.08), hypertension, dyslipidaemia, smoking and obesity (BMI ≥ 25) as key risk factors. MI incidence increased by 3.14% nationally from 2021 to 2023. Conclusions: China's MI burden is escalating, with notable gender, age and residence disparities. Older adults and individuals with hypertension, dyslipidaemia, smoking or obesity face elevated risks. Hypertension contributes to nearly two-thirds of MI cases, emphasising the urgency for targeted prevention strategies, particularly in high-risk groups (hypertensive individuals, older adults and urban populations).

中国高血压和心肌梗死负担:来自国家慢性病监测研究(2021-2023)的危险因素、性别差异和时间趋势
背景:心肌梗死(MI)仍然是全球发病率和死亡率的主要原因,在中国患病率不断上升。高血压仍然是一个主要的可改变的危险因素。本研究利用中国疾病预防控制中心慢性病监测项目的数据调查心肌梗死的患病率、趋势和危险因素。方法:对来自258,742名参与者(2021-2023)的数据进行分析。评估心肌梗死患病率的人口统计学特征、危险因素和性别/城乡差异。多因素logistic回归确定了显著的危险因素。结果:高血压是心肌梗死的主要危险因素(64.3%),其次是血脂异常(58.6%)和吸烟(42.3%)。男性的心肌梗死患病率高于女性(58.2%对41.8%),城市居民超过农村居民(56.7%对43.3%),生活方式存在显著差异(如缺乏运动、吸烟)。多因素分析发现,年龄≥60岁(OR = 2.75, 95% CI:2.46-3.08)、高血压、血脂异常、吸烟和肥胖(BMI≥25)是关键危险因素。从2021年到2023年,全国心肌梗死发病率增加了3.14%。结论:中国的MI负担正在升级,性别、年龄和居住地差异显著。老年人和患有高血压、血脂异常、吸烟或肥胖的人面临更高的风险。高血压占心肌梗死病例的近三分之二,这强调了制定有针对性的预防策略的紧迫性,特别是在高危人群(高血压患者、老年人、城市人口)中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Blood Pressure
Blood Pressure Medicine-Cardiology and Cardiovascular Medicine
CiteScore
3.20
自引率
5.60%
发文量
41
期刊介绍: For outstanding coverage of the latest advances in hypertension research, turn to Blood Pressure, a primary source for authoritative and timely information on all aspects of hypertension research and management. Features include: • Physiology and pathophysiology of blood pressure regulation • Primary and secondary hypertension • Cerebrovascular and cardiovascular complications of hypertension • Detection, treatment and follow-up of hypertension • Non pharmacological and pharmacological management • Large outcome trials in hypertension.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信